| GeneSymbol | Genbank | Fold Change | Description | |||||
| ACK1 | NM_005781.2 | 1.68 | activated p21cdc42Hs kinase | |||||
| ADAM19 | Y13786.2 | 1.95 | a disintegrin and metalloproteinase domain 19 | |||||
| ADAMDEC1 | NM_014479.1 | 2.18 | ADAM-like, decysin 1 | |||||
| ADAR | NM_001111.2 | 1.91 | adenosine deaminase, RNA-specific | |||||
| ADPRTL3 | AF083068.1 | 1.68 | ADP-ribosyltransferase | |||||
| AGRN | AI424797 | 1.84 | agrin | |||||
| AIM2 | NM_004833.1 | 1.8 | absent in melanoma 2 | |||||
| AKAP2 | NM_007203.1 | 2.15 | A kinase (PRKA) anchor protein 2 | |||||
| ANKHZN | NM_016376.1 | 2.05 | ANKHZN protein | |||||
| APOBEC3A | U03891.2 | 19.16 | apolipoprotein B mRNA editing enzyme, | |||||
| APOL1 | AF323540.1 | 2.97 | apolipoprotein L, 1 | |||||
| APOL3 | NM_014349.1 | 2.18 | apolipoprotein L, 3 | |||||
| APOL6 | NM_030641.1 | 3.18 | apolipoprotein L, 6 | |||||
| ARHGAP8 | AA533284 | 1.5 | Rho GTPase activating protein 8 | |||||
| ARHGEF11 | NM_014784.1 | 1.67 | Rho guanine nucleotide exchange factor (GEF) 11 | |||||
| ARHGEF3 | NM_019555.1 | 1.77 | Rho guanine nucleotide exchange factor (GEF) 3 | |||||
| ATF3 | NM_001674.1 | 4.53 | activating transcription factor 3 | |||||
| ATF4 | NM_001675.1 | 1.31 | activating transcription factor 4 (tax-responsive enhancer element B67) | |||||
| ATOX1 | NM_004045.1 | 1.68 | ATX1 antioxidant protein 1 homolog (yeast) | |||||
| ATP10A | N35112 | 2.68 | ATPase, Class V, type 10A | |||||
| B4GALT5 | BF691447 | 2.06 | UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 5 | |||||
| BAG1 | AF116273.1 | 1.89 | BCL2-associated athanogene | |||||
| BAZ1A | NM_013448.1 | 1.65 | bromodomain adjacent to zinc finger domain, 1A | |||||
| BCLG | NM_030766.1 | 4.17 | apoptosis regulator BCL-G | |||||
| BCRP1 | AV755522 | 3.82 | clone IMAGE:4074138, mRNA, mRNA sequence | |||||
| BF | NM_001710.1 | 7.85 | B-factor, properdin | |||||
| BLNK | NM_013314.1 | 1.88 | B-cell linker | |||||
| BLVRA | AA740186 | 2.78 | biliverdin reductase A | |||||
| BRD2 | D42040.1 | 1.42 | bromodomain containing 2 | |||||
| BRDG1 | NM_012108.1 | 2.29 | BCR downstream signaling 1 | |||||
| BST2 | NM_004335.2 | 4.09 | bone marrow stromal cell antigen 2 | |||||
| BTN2A1 | NM_007049.1 | 1.41 | butyrophilin, subfamily 2, member A1 | |||||
| BTN3A1 | NM_007048.1 | 1.58 | butyrophilin, subfamily 3, member A1 | |||||
| BTN3A3 | NM_006994.2 | 1.61 | butyrophilin, subfamily 3, member A3 | |||||
| C12orf6 | NM_020367.1 | 2.19 | chromosome 12 open reading frame 6 | |||||
| C14orf3 | NM_012111.1 | 1.26 | chromosome 14 open reading frame 3 | |||||
| C1GALT1 | NM_020156.1 | 1.73 | core 1 UDP-galactose:N-acetylgalactosamine-alpha-R beta 1,3-galactosyltransferase | |||||
| C1orf28 | NM_024529.1 | 1.74 | chromosome 1 open reading frame 28 | |||||
| C1orf29 | NM_006820.1 | 4.72 | chromosome 1 open reading frame 29 | |||||
| C20orf18 | BE788439 | 1.78 | chromosome 20 open reading frame 18 | |||||
| C4S-2 | NM_018641.1 | 2.63 | chondroitin 4-O-sulfotransferase 2 | |||||
| C6orf37 | AW246673 | 3.77 | chromosome 6 open reading frame 37 | |||||
| C7orf14 | AW008531 | 1.46 | chromosome 7 open reading frame 14 | |||||
| CACNA1A | AA769818 | 2.78 | calcium channel, voltage-dependent, P/Q type, alpha 1A subunit | |||||
| CAPN2 | M23254.1 | 1.56 | calpain 2, (m/II) large subunit | |||||
| CASP1 | U13699.1 | 2.42 | caspase 1, apoptosis-related cysteine protease | |||||
| CASP10 | NM_001230.1 | 2.18 | caspase 10, apoptosis-related cysteine protease | |||||
| CASP4 | AL050391.1 | 1.55 | caspase 4, apoptosis-related cysteine protease | |||||
| CASP7 | NM_001227.1 | 1.61 | caspase 7, apoptosis-related cysteine protease | |||||
| CAST | AF327443.1 | 1.59 | calpastatin | |||||
| CBR1 | BC002511.1 | 2.45 | carbonyl reductase 1 | |||||
| CCL8 | AI984980 | 14.49 | chemokine (C-C motif) ligand 8 | |||||
| CCND3 | NM_001760.1 | 1.36 | cyclin D3 | |||||
| CCR1 | AI421071 | 2.01 | chemokine (C-C motif) receptor 1 | |||||
| CCR5 | NM_000579.1 | 1.57 | chemokine (C-C motif) receptor 5 | |||||
| CD164 | AF263279.1 | 2 | CD164 antigen, sialomucin | |||||
| CD2AP | NM_012120.1 | 2.28 | CD2-associated protein | |||||
| CD38 | NM_001775.1 | 6.69 | CD38 antigen (p45) | |||||
| CD47 | BG230614 | 1.27 | CD47 antigen (integrin-associated signal transducer) | |||||
| CD69 | L07555.1 | 1.81 | CD69 antigen (p60, early T-cell activation antigen) | |||||
| CD80 | NM_005191.1 | 2.42 | CD80 antigen (CD28 antigen ligand 1, B7-1 antigen) | |||||
| CD83 | NM_004233.1 | 2.03 | CD83 antigen | |||||
| CEB1 | NM_016323.1 | 9.6 | cyclin-E binding protein 1 | |||||
| CECR1 | NM_017424.1 | 2.1 | cat eye syndrome chromosome region | |||||
| CENTD1 | AB011152.1 | 1.41 | centaurin, delta 1 | |||||
| CFLAR | AF041461.1 | 1.79 | CASP8 and FADD-like apoptosis regulator | |||||
| CHSY1 | NM_014918.1 | 1.43 | carbohydrate (chondroitin) synthase 1 | |||||
| cig5 | AI337069 | 18.65 | vipirin | |||||
| CKS1B | NM_001826.1 | 1.37 | CDC28 protein kinase regulatory subunit 1B | |||||
| CMT2 | NM_014628.1 | 1.33 | gene predicted from cDNA with a complete coding sequence | |||||
| CNP | BC001362.1 | 1.75 | 2`,3`-cyclic nucleotide 3` phosphodiesterase | |||||
| COPEB | BE675435 | 2.16 | core promoter element binding protein | |||||
| COX17 | NM_005694.1 | 1.42 | COX17 homolog, cytochrome c oxidase assembly protein (yeast) | |||||
| CRACC | NM_021181.2 | 3.98 | 19A24 protein | |||||
| CREG | NM_003851.1 | 1.78 | cellular repressor of E1A-stimulated genes | |||||
| CRFG | NM_012341.1 | 1.33 | G protein-binding protein CRFG | |||||
| CRSP6 | AF105421.1 | 1.36 | cofactor required for Sp1 transcriptional activation, subunit 6, | |||||
| CXCL10 | NM_001565.1 | 30.6 | chemokine (C-X-C motif) ligand 10 | |||||
| CXCL11 | AF002985.1 | 56.27 | chemokine (C-X-C motif) ligand 11 | |||||
| CXCL9 | NM_002416.1 | 2.93 | chemokine (C-X-C motif) ligand 9 | |||||
| CYCS | BC005299.1 | 1.29 | cytochrome c, somatic | |||||
| D13S106E | NM_005800.1 | 1.33 | highly charged protein | |||||
| DAPP1 | NM_014395.1 | 1.66 | dual adaptor of phosphotyrosine and 3-phosphoinositides | |||||
| DC13 | NM_020188.1 | 1.37 | DC13 protein | |||||
| DCK | NM_000788.1 | 1.74 | deoxycytidine kinase | |||||
| DDX1 | NM_004939.1 | 1.21 | DEAD/H (Asp-Glu-Ala-Asp/His) box polypeptide 1 | |||||
| DEFB1 | U73945.1 | 1.82 | defensin, beta 1 | |||||
| DISC1 | NM_018662.1 | 1.61 | disrupted in schizophrenia 1 | |||||
| DNMT1 | NM_001379.1 | 1.31 | DNA (cytosine-5-)-methyltransferase 1 | |||||
| DNPEP | NM_012100.1 | 1.44 | aspartyl aminopeptidase | |||||
| DRAP1 | NM_006442.1 | 1.72 | DR1-associated protein 1 (negative cofactor 2 alpha) | |||||
| DUSP5 | U16996.1 | 2.69 | dual specificity phosphatase 5 | |||||
| E2-EPF | NM_014501.1 | 1.62 | ubiquitin carrier protein | |||||
| ECE1 | BF969352 | 1.82 | clone IMAGE:4845226, mRNA, mRNA sequence | |||||
| ECGF1 | AW613387 | 2.02 | endothelial cell growth factor 1 (platelet-derived) | |||||
| ELF1 | AL559590 | 1.53 | E74-like factor 1 (ets domain transcription factor) | |||||
| ENPP2 | L35594.1 | 2.68 | ectonucleotide pyrophosphatase/phosphodiesterase 2 (autotaxin) | |||||
| FBXO7 | NM_012179.1 | 1.21 | F-box only protein 7 | |||||
| FEM1C | AI862658 | 1.44 | fem-1 homolog c (C.elegans) | |||||
| FLN29 | NM_006700.1 | 5.53 | FLN29 gene product | |||||
| FMR1 | AI743037 | 1.58 | fragile X mental retardation 1 | |||||
| FUT4 | AF305083.1 | 2.03 | fucosyltransferase 4 (alpha (1,3) | |||||
| G1P2 | NM_005101.1 | 9.86 | interferon, alpha-inducible protein (clone IFI-15K) | |||||
| GIP3 | NM_022873.1 | 4.36 | interferon, alpha-inducible protein (clone IFI-6-16) | |||||
| GADD45B | AF078077.1 | 1.67 | growth arrest and DNA-damage-inducible, beta | |||||
| GBP1 | NM_002053.1 | 4.43 | guanylate binding protein 1, interferon-inducible, 67kDa | |||||
| GBP2 | NM_004120.2 | 1.62 | guanylate binding protein 2, interferon-inducible | |||||
| GCH1 | NM_000161.1 | 3.03 | GTP cyclohydrolase 1 (dopa-responsive dystonia) | |||||
| GG2-1 | BC005352.1 | 1.63 | TNF-induced protein | |||||
| GLS | AF097493.1 | 1.47 | glutaminase | |||||
| GNG5 | NM_005274.1 | 1.4 | guanine nucleotide binding protein (G protein), gamma 5 | |||||
| GPR43 | NM_005306.1 | 4.7 | G protein-coupled receptor 43 | |||||
| GRP3 | NM_015376.1 | 3.36 | guanine nucleotide exchange factor for Rap1 | |||||
| GTF2B | NM_001514.2 | 1.46 | general transcription factor IIB | |||||
| GTPBP1 | NM_004286.1 | 1.5 | GTP binding protein 1 | |||||
| GTPBP2 | NM_019096.1 | 2.09 | GTP binding protein 2 | |||||
| H2AFO | NM_003516.1 | 1.85 | H2A histone family, member O | |||||
| H3F3B | NM_005324.1 | 1.31 | H3 histone, family 3B (H3.3B) | |||||
| HCC8 | NM_016516.1 | 1.41 | tumor antigen SLP-8p | |||||
| HDAC9 | NM_014707.1 | 1.97 | histone deacetylase 9 | |||||
| HESX1 | U82811.1 | 18.71 | homeo box (expressed in ES cells) 1 | |||||
| HIMAP4 | NM_018326.1 | 1.77 | immunity associated protein 4 | |||||
| HLA-B | L07950.1 | 1.2 | major histocompatibility complex, class I, B | |||||
| HLA-C | U62824.1 | 1.43 | major histocompatibility complex, class I, C | |||||
| HLA-DPA1 | M27487.1 | 1.81 | major histocompatibility complex, class II, DP alpha 1 | |||||
| HLA-DQA1 | BG397856 | 2.09 | major histocompatibility complex, class II, DQ alpha 1 | |||||
| HLA-E | M31183.1 | 1.58 | major histocompatibility complex, class I, E | |||||
| HLA-F | NM_018950.1 | 1.35 | major histocompatibility complex, class I, F | |||||
| HLA-G | M90684.1 | 1.37 | HLA-G histocompatibility antigen, class I, G | |||||
| HNRPF | AI591354 | 1.53 | heterogeneous nuclear ribonucleoprotein F | |||||
| HSPA1A | NM_005345.3 | 1.82 | heat shock 70kDa protein 1A | |||||
| HSPA8 | AF352832.1 | 1.38 | heat shock 70kDa protein 8 | |||||
| HSPB1 | NM_001540.2 | 1.96 | heat shock 27kDa protein 1 | |||||
| HSPCA | BG420237 | 1.38 | heat shock 90kDa protein 1, alpha | |||||
| HSXIAPAF1 | NM_017523.1 | 3.95 | XIAP associated factor-1 | |||||
| IDH3A | AI826060 | 2.37 | isocitrate dehydrogenase 3 (NAD+) alpha | |||||
| IFI16 | BG256677 | 2.53 | interferon, gamma-inducible protein 16 | |||||
| IFI27 | NM_005532.1 | 36.85 | interferon, alpha-inducible protein 27 | |||||
| IFI35 | BC001356.1 | 5.63 | interferon-induced protein 35 | |||||
| IFI44 | BE049439 | 7.91 | interferon-induced protein 44 | |||||
| IFIT1 | NM_001548.1 | 19.51 | interferon-induced protein with tetratricopeptide repeats 1 | |||||
| IFIT2 | BE888744 | 15.37 | interferon-induced protein with tetratricopeptide repeats 2 | |||||
| IFIT4 | NM_001549.1 | 11.69 | interferon-induced protein with tetratricopeptide repeats 4 | |||||
| IFITM2 | NM_006435.1 | 2.81 | interferon induced transmembrane protein 2 (1-8D) | |||||
| IFITM3 | BF338947 | 3.38 | interferon induced transmembrane protein 3 (1-8U) | |||||
| IFRG28 | NM_022147.1 | 5.45 | 28kD interferon responsive protein | |||||
| IL15 | NM_000585.1 | 2.13 | interleukin 15 | |||||
| IL15RA | NM_002189.1 | 3.46 | interleukin 15 receptor, alpha | |||||
| IL1RN | AW083357 | 6.77 | interleukin 1 receptor antagonist | |||||
| INDO | M34455.1 | 4.52 | indoleamine-pyrrole 2,3 dioxygenase | |||||
| INPP1 | NM_002194.2 | 1.56 | inositol polyphosphate-1-phosphatase | |||||
| IRF2 | NM_002199.2 | 2.06 | interferon regulatory factor 2 | |||||
| IRF4 | NM_002460.1 | 1.74 | interferon regulatory factor 4 | |||||
| IRF7 | NM_004030.1 | 4.37 | interferon regulatory factor 7 | |||||
| ISG20 | NM_002201.2 | 6.26 | interferon stimulated gene 20kDa | |||||
| ISGF3G | NM_006084.1 | 1.56 | interferon-stimulated transcription factor 3, gamma 48kDa | |||||
| JAK2 | AF001362.1 | 3.22 | Janus kinase 2 (a protein tyrosine kinase) | |||||
| KARS | AF285758.1 | 1.3 | lysyl-tRNA synthetase | |||||
| KCNE1L | NM_012282.1 | 4.6 | potassium voltage-gated channel, Isk-related family, member 1-like | |||||
| KCNJ2 | AF153820.1 | 3 | potassium inwardly-rectifying channel, subfamily J, member 2 | |||||
| KLRD1 | U30610.1 | 1.52 | killer cell lectin-like receptor subfamily D, member 1 | |||||
| KPNB1 | L38951.1 | 1.7 | karyopherin (importin) beta 1 | |||||
| LAG3 | NM_002286.3 | 3.56 | lymphocyte-activation gene 3 | |||||
| LAMP2 | J04183.1 | 1.74 | lysosomal-associated membrane protein 2 | |||||
| LAMP3 | NM_014398.1 | 3.19 | lysosomal-associated membrane protein 3 | |||||
| LAP3 | NM_015907.1 | 3.88 | leucine aminopeptidase 3 | |||||
| LDLR | NM_000527.2 | 1.85 | low density lipoprotein receptor (familial hypercholesterolemia) | |||||
| LGALS3BP | NM_005567.2 | 3.62 | lectin, galactoside-binding, soluble, 3 binding protein | |||||
| LGALS9 | NM_009587.1 | 4.65 | lectin, galactoside-binding, soluble, 9 (galectin 9) | |||||
| LGP2 | NM_024119.1 | 5.6 | likely ortholog of mouse D11lgp2 | |||||
| LLT1 | NM_013269.1 | 2.43 | lectin-like NK cell receptor | |||||
| LPIN2 | U55968 | 1.63 | lipin 2 | |||||
| LRRFIP2 | NM_006309.1 | 1.35 | leucine rich repeat (in FLII) interacting protein 2 | |||||
| LY6E | NM_002346.1 | 8.43 | lymphocyte antigen 6 complex, locus E | |||||
| MAGED2 | AF320070.1 | 2.11 | melanoma antigen, family D, 2 | |||||
| MARCKS | AW163148 | 2 | myristoylated alanine-rich protein kinase C substrate | |||||
| MCL1 | NM_021960.1 | 1.79 | myeloid cell leukemia sequence 1 (BCL2-related) | |||||
| MDA5 | NM_022168.1 | 5.96 | melanoma differentiation associated protein-5 | |||||
| MEF2A | X63381.1 | 1.57 | MADS box transcription enhancer factor 2, polypeptide A | |||||
| MEL | BC002977.1 | 1.59 | mel transforming oncogene (derived from cell line NK14)- RAB8 homolog | |||||
| MICA | NM_000247.1 | 1.43 | MHC class I polypeptide-related sequence A | |||||
| MICB | NM_005931.1 | 1.73 | MHC class I polypeptide-related sequence B | |||||
| MKRN1 | NM_013446.1 | 1.46 | makorin, ring finger protein, 1 | |||||
| MLCB | NM_006471.1 | 1.32 | myosin, light polypeptide, regulatory, non-sarcomeric (20kD) | |||||
| MNDA | NM_002432.1 | 6.21 | myeloid cell nuclear differentiation antigen | |||||
| MRPL42 | BE782148 | 1.64 | mitochondrial ribosomal protein L42 | |||||
| MRPS28 | NM_014018.1 | 1.37 | mitochondrial ribosomal protein S28 | |||||
| MRS3/4 | NM_031212.1 | 1.69 | putative mitochondrial solute carrier | |||||
| MTHFD2 | NM_006636.2 | 1.54 | methylene tetrahydrofolate dehydrogenase (NAD+ dependent), | |||||
| MX1 | NM_002462.1 | 7.3 | myxovirus (influenza virus) resistance 1, | |||||
| MX2 | NM_002463.1 | 5.66 | myxovirus (influenza virus) resistance 2 (mouse) | |||||
| MYD88 | U70451.1 | 1.56 | myeloid differentiation primary response gene (88) | |||||
| N4BP1 | NM_014664.1 | 2.24 | Nedd4 binding protein 1 | |||||
| NAGK | NM_017567.1 | 1.85 | N-acetylglucosamine kinase | |||||
| NAPA | NM_003827.1 | 2.37 | N-ethylmaleimide-sensitive factor attachment protein, alpha | |||||
| NAT1 | NM_000662.1 | 1.29 | N-acetyltransferase 1 (arylamine N-acetyltransferase) | |||||
| NBS1 | AI796269 | 3.26 | Nijmegen breakage syndrome 1 (nibrin) | |||||
| NDP52 | BC004130.1 | 1.32 | nuclear domain 10 protein | |||||
| NFE2L3 | NM_004289.3 | 2.09 | nuclear factor (erythroid-derived 2)-like 3 | |||||
| NMI | NM_004688.1 | 2.84 | N-myc (and STAT) interactor | |||||
| NMT1 | AF020500.1 | 1.38 | N-myristoyltransferase 1 | |||||
| NR4A3 | U12767.1 | 3.69 | nuclear receptor subfamily 4, group A, member 3 | |||||
| NY-REN-34 | BF055474 | 2.31 | putative zinc finger protein NY-REN-34 antigen | |||||
| OAS1 | NM_002534.1 | 14.3 | 2`,5`-oligoadenylate synthetase 1, 40/46kDa | |||||
| OAS2 | NM_016817.1 | 5.13 | 2`-5`-oligoadenylate synthetase 2, 69/71kDa | |||||
| OAS3 | NM_006187.1 | 11.88 | 2`-5`-oligoadenylate synthetase 3, 100kDa | |||||
| OASL | NM_003733.1 | 6.14 | 2`-5`-oligoadenylate synthetase-like | |||||
| OGFR | NM_007346.1 | 1.34 | opioid growth factor receptor | |||||
| ORC3L | AF125507.1 | 1.28 | origin recognition complex, subunit 3-like (yeast) | |||||
| P2RX7 | NM_002562.1 | 2.86 | purinergic receptor P2X, ligand-gated ion channel, 7 | |||||
| P5-1 | NM_006674.1 | 1.38 | MHC class I region ORF | |||||
| PC4 | NM_006713.1 | 1.42 | activated RNA polymerase II transcription cofactor 4 | |||||
| PCTAIRE2BP | AW129593 | 3.11 | tudor repeat associator with PCTAIRE 2 | |||||
| PDGFRL | NM_006207.1 | 6.54 | platelet-derived growth factor receptor-like | |||||
| PDZ-GEF1 | NM_014247.1 | 1.79 | PDZ domain containing guanine nucleotide exchange factor(GEF)1 | |||||
| PELI1 | NM_020651.2 | 1.81 | pellino homolog 1 (Drosophila) | |||||
| PFKP | NM_002627.1 | 1.57 | phosphofructokinase, platelet | |||||
| PIP3-E | AW166711 | 1.77 | phosphoinositide-binding protein PIP3-E | |||||
| PKD2 | AF309082.1 | 1.86 | protein kinase D2 | |||||
| PLAC8 | NM_016619.1 | 1.91 | placenta-specific 8 | |||||
| PLEK | NM_002664.1 | 2.01 | pleckstrin | |||||
| PLSCR1 | AI825926 | 3.43 | phospholipid scramblase 1 | |||||
| PMAIP1 | AI857639 | 2.33 | phorbol-12-myristate-13-acetate-induced protein 1 | |||||
| PML | AF230411.1 | 6.78 | promyelocytic leukemia | |||||
| PMSCL1 | NM_005033.1 | 1.83 | polymyositis/scleroderma autoantigen 1, 75kDa | |||||
| POLS | NM_006999.2 | 1.42 | polymerase (DNA directed) sigma | |||||
| PORIMIN | BG538627 | 1.51 | pro-oncosis receptor inducing membrane injury gene | |||||
| PPP1CC | NM_002710.1 | 1.37 | protein phosphatase 1, catalytic subunit, gamma isoform | |||||
| PPP2R2A | NM_002717.1 | 1.51 | protein phosphatase 2 (formerly 2A), regulatory subunit B (PR 52), alpha isoform | |||||
| PPP3CC | NM_005605.1 | 1.42 | protein phosphatase 3 (formerly 2B), catalytic subunit, gamma isoform (calcineurin A gamma) | |||||
| PRDX4 | NM_006406.1 | 1.66 | peroxiredoxin 4 | |||||
| PRF1 | AI445650 | 1.82 | Perforin, mRNA sequence | |||||
| PRKAG2 | NM_016203.1 | 1.57 | protein kinase, AMP-activated, gamma 2 non-catalytic subunit | |||||
| PRKR | NM_002759.1 | 3.3 | protein kinase, interferon-inducible double stranded RNA dependent | |||||
| PSCD1 | NM_004762.1 | 1.32 | pleckstrin homology, Sec7 and coiled/coil domains 1(cytohesin 1) | |||||
| PSMA2 | NM_002787.1 | 1.61 | proteasome (prosome, macropain) subunit, alpha type, 2 | |||||
| PSMA3 | NM_002788.1 | 1.59 | proteasome (prosome, macropain) subunit, alpha type, 3 | |||||
| PSMA4 | NM_002789.1 | 1.58 | proteasome (prosome, macropain) subunit, alpha type, 4 | |||||
| PSMA5 | NM_002790.1 | 1.53 | proteasome (prosome, macropain) subunit, alpha type, 5 | |||||
| PSMA6 | BC002979.1 | 1.56 | proteasome (prosome, macropain) subunit, alpha type, 6 | |||||
| PSMB10 | NM_002801.1 | 1.63 | proteasome (prosome, macropain) subunit, beta type, 10 | |||||
| PSMB2 | NM_002794.1 | 1.34 | proteasome (prosome, macropain) subunit, beta type, 2 | |||||
| PSMB8 | U17496.1 | 2.03 | proteasome (prosome, macropain) subunit, beta type, 8 (large multifunctional protease 7) | |||||
| PSMB9 | NM_002800.1 | 2.07 | proteasome (prosome, macropain) subunit, beta type, 9 (large multifunctional protease 2) | |||||
| PSMC2 | NM_002803.1 | 1.21 | proteasome (prosome, macropain) 26S subunit, ATPase, 2 | |||||
| PSME1 | NM_006263.1 | 1.53 | proteasome (prosome, macropain) activator subunit 1 (PA28 alpha) | |||||
| PSME2 | NM_002818.1 | 1.77 | proteasome (prosome, macropain) activator subunit 2 (PA28 beta) | |||||
| PTS | NM_003641.1 | 2.62 | 6-pyruvoyltetrahydropterin synthase | |||||
| QKI | AI114716 | 1.54 | homolog of mouse quaking QKI (KH domain RNA binding protein) | |||||
| RAB7L1 | BC002585.1 | 1.49 | RAB7, member RAS oncogene family-like 1 | |||||
| RALB | BG169673 | 1.75 | v-ral simian leukemia viral oncogene homolog B (ras related; GTP binding protein) | |||||
| RAN | AF054183.1 | 1.22 | RAN, member RAS oncogene family | |||||
| RANBP20 | AL546600 | 1.22 | RAN binding protein 20 | |||||
| RANGAP1 | NM_002883.1 | 1.44 | Ran GTPase activating protein 1 | |||||
| RARRES3 | NM_004585.2 | 1.38 | retinoic acid receptor responder (tazarotene induced) 3 | |||||
| RBM7 | NM_016090.1 | 1.52 | RNA binding motif protein 7 | |||||
| RDX | AI057093 | 1.96 | radixin | |||||
| RFX5 | AW027312 | 1.56 | regulatory factor X, 5 (influences HLA class II expression) | |||||
| RGL | AF186779.1 | 2.01 | RalGDS-like gene | |||||
| RGS1 | S59049.1 | 3.85 | B cell activation gene [Homo sapiens], mRNA sequence | |||||
| RI58 | N47725 | 4.49 | retinoic acid- and interferon-inducible protein (58kD) | |||||
| RICH1 | NM_018054.1 | 1.49 | homolog of rat nadrin | |||||
| RIG-I | NM_014314.1 | 6.22 | DEAD/H (Asp-Glu-Ala-Asp/His) box polypeptide | |||||
| RIPK1 | U50062.1 | 1.85 | receptor (TNFRSF)-interacting serine-threonine kinase 1 | |||||
| RIPK2 | AF064824.1 | 2.09 | receptor-interacting serine-threonine kinase 2 | |||||
| RPLP2 | NM_001444.1 | 2.01 | ribosomal protein, large P2 | |||||
| SAMHD1 | NM_015474.1 | 1.72 | SAM domain and HD domain 1 | |||||
| SAMSN1 | NM_022136.1 | 1.4 | SAM domain, SH3 domain and nuclear localisation signals, 1 | |||||
| SAT | BE971383 | 2.47 | spermidine/spermine N1-acetyltransferase | |||||
| SC4MOL | AV704962 | 1.7 | sterol-C4-methyl oxidase-like | |||||
| SCARB2 | NM_005506.1 | 1.8 | scavenger receptor class B, member 2 | |||||
| SCO2 | NM_005138.1 | 2.51 | SCO cytochrome oxidase deficient homolog 2 (yeast) | |||||
| SEC5 | NM_018303.1 | 1.44 | homolog of yeast Sec5 | |||||
| SERPINB1 | NM_030666.1 | 1.86 | serine (or cysteine) proteinase inhibitor, clade B (ovalbumin), member 1 | |||||
| SERPING1 | NM_000062.1 | 7.73 | serine (or cysteine) proteinase inhibitor, clade G (C1 inhibitor), member 1, | |||||
| SH3GLB1 | AF263293.1 | 1.5 | SH3-domain GRB2-like endophilin B1 | |||||
| SIAT9 | NM_003896.1 | 1.63 | sialyltransferase 9 (CMP-NeuAc:lactosylceramide alpha-2,3-sialyltransferase) | |||||
| SLC37A1 | NM_018964.1 | 2.49 | solute carrier family 37 (glycerol-3-phosphate transporter), member 1 | |||||
| SMC6 | NM_024624.1 | 1.32 | SMC6 protein | |||||
| SN | NM_023068.1 | 132.52 | sialoadhesin | |||||
| SNX11 | NM_013323.1 | 1.76 | sorting nexin 11 | |||||
| SNX6 | NM_021249.1 | 1.48 | sorting nexin 6 | |||||
| SOAT1 | L21934.2 | 1.71 | sterol O-acyltransferase (acyl-Coenzyme A: cholesterol acyltransferase) 1 | |||||
| SOCS1 | AB005043.1 | 1.96 | suppressor of cytokine signaling 1 | |||||
| SOCS2 | AB004903.1 | 2.01 | suppressor of cytokine signaling 2 | |||||
| SOS1 | AA700167 | 1.59 | son of sevenless homolog 1 (Drosophila) | |||||
| SP100 | NM_003113.1 | 2.52 | nuclear antigen Sp100 | |||||
| SP110 | AF280094.1 | 2.49 | SP110 nuclear body protein | |||||
| SP140 | NM_007237.1 | 1.74 | SP140 nuclear body protein | |||||
| SPTLC2 | U15555.1 | 3.06 | serine palmitoyltransferase, long chain base subunit 2 | |||||
| SQRDL | NM_021199.1 | 1.81 | sulfide dehydrogenase like (yeast) | |||||
| SRI | L12387.1 | 1.28 | sorcin | |||||
| SSA1 | NM_003141.1 | 1.98 | Sjogren syndrome antigen A1 (52kDa, ribonucleoprotein autoantigen SS-A/Ro) | |||||
| SSB | BG532929 | 1.51 | Sjogren syndrome antigen B (autoantigen La) | |||||
| STARD7 | NM_020151.1 | 1.26 | START domain containing 7 | |||||
| STAT1 | BC002704.1 | 3.27 | signal transducer and activator of transcription 1, 91kDa | |||||
| STAT2 | S81491 | 3.81 | Stat2 type a | |||||
| STAU | AJ132258.1 | 1.3 | staufen, RNA binding protein (Drosophila) | |||||
| STX11 | AF071504.1 | 3.06 | syntaxin 11 | |||||
| SUCLG2 | BF593940 | 1.33 | succinate-CoA ligase, GDP-forming, beta subunit | |||||
| SYNGR2 | NM_004710.1 | 1.51 | synaptogyrin 2 | |||||
| TANK | NM_004180.1 | 1.41 | TRAF family member-associated NFKB activator | |||||
| TAP1 | NM_000593.2 | 3.66 | transporter 1, ATP-binding cassette, sub-family B (MDR/TAP) | |||||
| TARBP1 | NM_005646.1 | 2.29 | TAR (HIV) RNA binding protein 1 | |||||
| TBC1D1 | AB029031.1 | 1.31 | TBC1 (tre-2/USP6, BUB2, cdc16) domain family, member 1 | |||||
| TCTEL1 | NM_006519.1 | 3.12 | t-complex-associated-testis-expressed 1-like 1 | |||||
| TEL2 | AF147782.1 | 1.99 | transcription factor ets | |||||
| TFEC | NM_012252.1 | 3.38 | transcription factor EC | |||||
| TIA1 | NM_022037.1 | 1.56 | TIA1 cytotoxic granule-associated RNA binding protein | |||||
| TINF2 | NM_012461.1 | 1.49 | TERF1 (TRF1)-interacting nuclear factor 2 | |||||
| TLR7 | NM_016562.1 | 3.07 | toll-like receptor 7 | |||||
| TNFAIP6 | AW188198 | 5.55 | tumor necrosis factor, alpha-induced protein 6 | |||||
| TNFRSF6 | X83493.1 | 2.64 | tumor necrosis factor receptor superfamily, member 6 | |||||
| TNFSF10 | AW474434 | 9 | tumor necrosis factor (ligand) superfamily, member 10 | |||||
| TNFSF6 | D38122.1 | 1.54 | tumor necrosis factor (ligand) superfamily, member 6 | |||||
| TOP1 | J03250.1 | 1.52 | topoisomerase (DNA) I | |||||
| TOR1B | AF317129.1 | 2.26 | torsin family 1, member B (torsin B) | |||||
| TPO | AA164751 | 2.9 | EST | |||||
| TRADD | L41690.1 | 1.58 | TNFRSF1A-associated via death domain | |||||
| TRAF1 | NM_005658.1 | 1.62 | TNF receptor-associated factor 1 | |||||
| TREX1 | NM_016381.1 | 4.05 | three prime repair exonuclease 1 | |||||
| TRIM14 | NM_014788.1 | 2.03 | tripartite motif-containing 14 | |||||
| TRIM22 | AA083478 | 2.65 | tripartite motif-containing 22 | |||||
| TRIM26 | NM_003449.1 | 1.56 | tripartite motif-containing 26 | |||||
| TRIM34 | NM_021616.1 | 2.07 | tripartite motif-containing 34 | |||||
| TRIM38 | AI363270 | 2.25 | tripartite motif-containing 38 | |||||
| TRIM5 | AF220028.1 | 3.07 | tripartite motif-containing 5 | |||||
| TXNDC | AL080080.1 | 1.66 | thioredoxin domain containing | |||||
| TXNIP | AA812232 | 1.53 | thioredoxin interacting protein | |||||
| UBC | M26880.1 | 1.31 | ubiquitin C | |||||
| UBE1L | NM_003335.1 | 1.69 | ubiquitin-activating enzyme E1-like | |||||
| UBE2L6 | NM_004223.1 | 2.51 | ubiquitin-conjugating enzyme E2L 6 | |||||
| UBQLN2 | AK001029.1 | 1.39 | ubiquilin 2 | |||||
| UNC93B1 | NM_030930.1 | 2.87 | unc-93 homolog B1 (C. elegans) | |||||
| USP15 | AF153604.1 | 2.08 | ubiquitin specific protease 15 | |||||
| USP18 | NM_017414.1 | 10.43 | ubiquitin specific protease 18 | |||||
| USP25 | NM_013396.1 | 1.54 | ubiquitin specific protease 25 | |||||
| UTRN | NM_007124.1 | 1.87 | utrophin (homologous to dystrophin) | |||||
| UVRAG | NM_003369.1 | 1.65 | UV radiation resistance associated gene | |||||
| VAMP5 | NM_006634.1 | 1.48 | vesicle-associated membrane protein 5 (myobrevin) | |||||
| WARS | NM_004184.2 | 2.92 | tryptophanyl-tRNA synthetase | |||||
| WASPIP | NM_003387.2 | 1.4 | Wiskott-Aldrich syndrome protein interacting protein | |||||
| ZBP1 | NM_030776.1 | 3.5 | Z-DNA binding protein 1 | |||||
| ZFD25 | NM_016220.1 | 1.8 | zinc finger protein (ZFD25) | |||||
| ZNF147 | NM_005082.1 | 2.65 | zinc finger protein 147 (estrogen-responsive finger protein) | |||||
| ZNF267 | AU150728 | 1.55 | clone NT2RP7015789, highly similar to Zinc finger protein 267 | |||||
| ZNF313 | NM_018683.1 | 1.55 | zinc finger protein 313 |